SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns Hina Zahid31 Aug 2018 8:35 PM ISTThe Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
New Therapies for risk reduction in Diabetes with CVD: ACC guidance Medha Baranwal Baranwal29 Nov 2018 7:00 PM ISTThe American College of Cardiology has released new guidance on novel therapies for reduction of cardiovascular (CV) risk in patients with...
Canagliflozin use not linked to increased fracture risk in diabetes Hina Zahid2 Jan 2019 7:28 PM ISTIn a Population-based new-user cohort study researchers have found that Canagliflozin use is not linked to increased risk for fracture. The study has...
EMA approves first oral add-on to insulin for type 1 diabetes Hina Zahid7 Feb 2019 7:05 PM ISTThe European Medicines Agency (EMA) has recommended extending the licence for dapagliflozin to include an indication as an adjuvant treatment with...
Can we reduce cardiovascular risk in diabetes? Deepanjana Sarkar23 April 2019 7:02 PM ISTFor long, diabetes has always been considered as an endocrine disease and treated by endocrinologists for lowering glucose. The adverse outcomes of...
Hydroxychloroquine as good as SGLT-2 inhibitors as add on therapy to lower blood sugar Deepanjana Sarkar1 May 2019 8:28 PM ISTHydroxychloroquine is as good as SGLT-2 inhibitors (sodium-glucose transport inhibitors)as an add on treatment for lowering blood sugar and HbA1c in...
ADA 2019 Highlights: Primary And secondary Prevention Outcomes From CREDENCE Dr. Kartikeya16 Jun 2019 7:02 PM ISTThe CREDENCE Trial outcomes came as a big win for patients with Type 2 Diabetes Mellitus(T2DM) and Chronic Kidney Disease (CKD), considering the high...
